Tag: Patent
-
German firm Boehringer Ingelheim’s patent for asthma drug revoked – Economic Times
German firm Boehringer Ingelheim's patent for asthma drug revokedEconomic TimesMUMBAI: India's Patent Office has revoked a patent on asthma drug, Spiriva (tiotropium bromide monohydrate) held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla. The patent was revoked on grounds that it lacks …and more » View full post on asthma – Google…
-
German co’s patent for asthma drug revoked – Times of India
German co's patent for asthma drug revokedTimes of IndiaMUMBAI: India's Patent Office has revoked a patent on asthma drug, Spiriva (tiotropium bromide monohydrate) held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla. The patent was revoked on grounds that it lacks …and more » View full post on asthma – Google News
-
AstraZeneca’s patent on asthma drug invalidated by U.S. court – Business Insider
Business Insider AstraZeneca's patent on asthma drug invalidated by U.S. courtBusiness InsiderNEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …AstraZeneca plc (ADR)…
-
AstraZeneca’s patent on asthma drug invalidated by US court – Reuters
Reuters AstraZeneca's patent on asthma drug invalidated by US courtReutersNEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …Actavis launches Pulmicort Respules generic…
-
AstraZeneca’s patent on asthma drug invalidated by US court – Yahoo News
euronews AstraZeneca's patent on asthma drug invalidated by US courtYahoo NewsNEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …Actavis launches Pulmicort Respules…
-
AstraZeneca’s Kid Asthma Drug Patent Deemed Obvious – Law360 (subscription)
AstraZeneca's Kid Asthma Drug Patent Deemed ObviousLaw360 (subscription)Law360, Los Angeles (February 13, 2015, 4:49 PM ET) — A New Jersey federal judge on Friday opened the door for Sandoz Inc., Apotex Inc. and other competitors of AstraZeneca PLC to launch generic versions of its pediatric asthma medication, finding … View full post on asthma –…
-
City scientists patent asthma breakthrough – The Press
The Press City scientists patent asthma breakthroughThe PressWellington scientists have patented a ground-breaking vaccine for asthma. Trial results published today show the vaccine works in mice, preventing inflammation of the lungs and airways. The vaccine is a novel way of dealing with allergies which, …Wellington researchers discover new technology for asthma vaccineScoop.co.nz (press release)Asthma vaccine patented…
-
City scientists patent asthma breakthrough – Stuff.co.nz
Stuff.co.nz City scientists patent asthma breakthroughStuff.co.nzWellington scientists have patented a ground-breaking vaccine for asthma. Trial results published today show the vaccine works in mice, preventing inflammation of the lungs and airways. The vaccine is a novel way of dealing with allergies which, …and more » View full post on asthma – Google News
-
Teva Asthma Drug Would Infringe Mylan Patent, Judge Says – Law360 (subscription)
Teva Asthma Drug Would Infringe Mylan Patent, Judge SaysLaw360 (subscription)Law360, New York (July 17, 2013, 7:18 PM ET) — A West Virginia federal judge ruled Wednesday that an asthma treatment proposed by generic drugmaker Teva Pharmaceutical USA Inc. would violate a patent covering Mylan Inc.'s Perforomist treatment. View full post on asthma – Google News
-
AstraZeneca Loses US Patent Protection for Asthma Drug – Fox Business
IBTimes.co.uk AstraZeneca Loses US Patent Protection for Asthma DrugFox BusinessA patent protecting AstraZeneca's (AZN) Pulmicort Respules asthma drug in the U.S. was deemed invalid on Tuesday, paving the way for a generic version of the drug to hit store shelves. The company said on Tuesday a district court in New Jersey ruled in …AstraZeneca Loses…